Abstract
The study investigates the relationship between insulin resistance and metabolic syndrome and plasma procalcitonin, a biomarker of inflammation. The metabolic syndrome, a collection of disorders that includes dyslipidemia, hypertension, hyperglycemia, and abdominal obesity, raises the risk of type 2 diabetes and cardiovascular illnesses. One of the main elements of metabolic syndrome is insulin resistance. Adipocyte dysfunction and persistent low-grade inflammation may be markers for elevated levels of plasma procalcitonin, which have been linked to higher measures of obesity, metabolic syndrome components, and a higher chance of developing insulin resistance and metabolic syndrome.
Users
Please
log in to take part in the discussion (add own reviews or comments).